Literature DB >> 33798456

Pirfenidone in patients with non-IPF progressive fibrotic interstitial lung diseases: expert guidance is urgently needed.

Athol U Wells1.   

Abstract

Entities:  

Year:  2021        PMID： 33798456     DOI： 10.1016/S2213-2600(21)00173-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

1.  Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.

Authors:  James Patrick Finnerty; Aravind Ponnuswamy; Prosjenjit Dutta; Ammar Abdelaziz; Hafiz Kamil
Journal:  BMC Pulm Med       Date:  2021-12-11       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.